Public Profile

Edwards Lifesciences

Edwards Lifesciences Corporation, a leader in heart valve therapies and critical care monitoring, is headquartered in the United States. Founded in 1958, the company has established itself as a pioneer in the medical technology industry, particularly in the development of innovative solutions for patients with cardiovascular diseases. With a strong presence in North America, Europe, and Asia, Edwards Lifesciences focuses on advanced heart valve replacement and repair technologies, as well as haemodynamic monitoring systems. Their flagship products, including the transcatheter aortic valve replacement (TAVR) systems, are renowned for their unique design and effectiveness, significantly improving patient outcomes. Recognised for its commitment to innovation, Edwards Lifesciences has achieved numerous accolades, solidifying its position as a trusted name in the healthcare sector. The company continues to drive advancements in cardiac care, enhancing the quality of life for patients worldwide.

DitchCarbon Score

How does Edwards Lifesciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

63

Industry Average

Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

25

Industry Benchmark

Edwards Lifesciences's score of 63 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.

98%

Let us know if this data was useful to you

Edwards Lifesciences's reported carbon emissions

In 2023, Edwards Lifesciences reported total greenhouse gas emissions of approximately 571,389,000 kg CO2e, with emissions distributed across various scopes: 16,120,000 kg CO2e (Scope 1), 23,783,000 kg CO2e (Scope 2), and a significant 571,389,000 kg CO2e (Scope 3). The combined total for Scope 1 and Scope 2 emissions was about 39,903,000 kg CO2e. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2021 as the baseline year. Additionally, Edwards Lifesciences targets a 51.6% reduction in Scope 3 emissions per USD of value added within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are consistent with efforts to limit global warming to 1.5°C. Overall, Edwards Lifesciences is actively working towards significant emissions reductions, demonstrating a commitment to sustainability and climate responsibility within the pharmaceuticals and biotechnology sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201020112012201320142015201620172018201920202021202220232024
Scope 1
4,977,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
23,498,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000
000,000,000
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Edwards Lifesciences's primary industry is Computer and related services (72), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Edwards Lifesciences is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Edwards Lifesciences is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

B. Braun Melsungen AG

DE
Medical, precision and optical instruments, watches and clocks (33)
Updated about 2 months ago

CONMED Corporation

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Drager

DE
Machinery and equipment n.e.c. (29)
Updated about 23 hours ago

C. R. Bard, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 months ago
DitchCarbon Score

St. Jude Medical, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 months ago
DitchCarbon Score

Kensey Nash Corporation

US
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers